Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-25-000352
Accepted
2025-02-10 00:15:16
Documents
1
Effectiveness Date
2025-02-07

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 598
  Complete submission text file 9999999995-25-000352.txt   1905
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

EIN.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-284229 | Film No.: 25603473
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)